Raleigh Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.68K | Hold |
|
|||||
|
2024
Q3 | $2.5K | Hold |
|
|||||
|
2024
Q2 | $2.11K | Hold |
|
|||||
|
2024
Q1 | $1.83K | Hold |
|
|||||
|
2023
Q4 | $1.79K | Hold |
|
|||||
|
2023
Q3 | $1.5K | Sell |
|
|||||
|
2023
Q2 | $6.13K | Buy |
|
|||||
|
2023
Q1 | $4.63K | Buy |
|
|||||
|
2022
Q4 | $1.67K | Sell |
|
|||||
|
2022
Q3 | $2K | Hold |
|
|||||
|
2022
Q2 | $2K | Hold |
|
|||||
|
2022
Q1 | $3K | Buy |
|